ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/API/(D-Ser(tBu)6,D-Leu7,Azagly10)-LHRH
C59H84N18O14
1269.4 g/mol
API

(D-Ser(tBu)6,D-Leu7,Azagly10)-LHRH

CAS1926163-38-3
Category
API
Compound Class
Peptide
Primary Use
Pharmaceutical Raw Material

This compound is a synthetic decapeptide analog of luteinizing hormone-releasing hormone (LHRH). It is primarily used as an active pharmaceutical ingredient (API) in research and pharmaceutical manufacturing.

Pharmaceutical raw material for manufacturing LHRH analog peptideResearch compound for developing therapies targeting hormone-dependent conditions

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing (D-Ser(tBu)6,D-Leu7,Azagly10)-LHRH?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

ReferenceSame Category

Dexmethylphenidate hydrochloride

CAS19262-68-1

pharmaceutical raw material

ReferenceSame Category

1-TERT-BUTYL-3-[6-(2,6-DICHLOROPHENYL)-2-[[4-(DIETHYLAMINO)BUTYL]AMINO]PYRIDO[2,3-D]PYRIMIDIN-7-YL]UREA

CAS192705-80-9

pharmaceutical raw material

ReferenceSame Category

Lopinavir

CAS192725-17-0

pharmaceutical raw material

ReferenceSame Category

N-((2S,3S,5S)-5-amino-3-hydroxy-1,6-diphenylhexan-2-yl)-2-(2,6-dimethylphenoxy)acetamide

CAS192725-49-8

pharmaceutical raw material

Referencestereoisomer of

(2S)-1-((2S)-2-((2S)-2-((2R)-3-(tert-butoxy)-2-((2S)-2-((2R)-3-hydroxy-2-((2S)-2-((2S)-3-(1H-imidazol-5-yl)-2-(((2S)-5-oxopyrrolidin-2-yl)formamido)propanamido)-3-(1H-indol-3-yl)propanamido)propanamido)-3-(4-hydroxyphenyl)propanamido)propanamido)-4-methylpentanamido)-5-carbamimidamidopentanoyl)-N-(carbamoylamino)pyrrolidine-2-carboxamide

CAS1926163-39-4

pharmaceutical raw material

Referencestereoisomer of

Goserelin

CAS65807-02-5

pharmaceutical raw material

Referencestereoisomer of

(D-Tyr5,D-Ser(tBu)6,Azagly10)-LHRH

CAS1426173-74-1

research compound

Referencestereoisomer of

Goserelin acetate

CAS145781-92-6

pharmaceutical raw material

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more
Identifiers
IUPAC Name

(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2R)-1-[[(2S)-1-[(2S)-2-[(carbamoylamino)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxy]-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide

InChIKey

BLCLNMBMMGCOAS-HZLKSCACSA-N

SMILES

CC(C)C[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NNC(=O)N)NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CC5=CN=CN5)NC(=O)[C@@H]6CCC(=O)N6

Synonyms (3)
  • Goserelin EP Impurity L

Sourcing (D-Ser(tBu)6,D-Leu7,Azagly10)-LHRH?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→